Literature DB >> 7711423

The prognostic value of hypocholesterolemia in hospitalized patients.

E Windler1, U Ewers-Grabow, J Thiery, A Walli, D Seidel, H Greten.   

Abstract

Clinical observations show that severe illness often leads to hypocholesterolemia. To verify this finding and to define the relationship between serum cholesterol and a patient's prognosis, a study was conducted in two large hospital populations. Of 24,000 and 61,463 adult patients (populations I and II) an average of 3.8% and 3.6% died in hospital, respectively. The mean serum cholesterol levels of patients who died was significantly lower than that of those who survived (163.6 mg/dl versus 217.8 mg/dl; P < 0.0001). The average cholesterol of surviving patients was similar to that of 6,543 healthy controls. During hospitalization serum cholesterol levels of < or = 100 mg/dl were encountered in 1.2% and 3.6% of patients of populations I and II, respectively. The mortality of these hypocholesterolemic patients was about tenfold higher than average and showed a strong, inverse, linear relationship with serum cholesterol concentrations. Patients whose serum cholesterol level dropped to less than 45 mg/dl did not survive. These data show that in severely ill patients serum cholesterol may decline to very low concentrations, and the prognosis is reflected by the degree of hypocholesterolemia, which thus may serve as a clinically useful prognostic parameter.

Entities:  

Mesh:

Year:  1994        PMID: 7711423     DOI: 10.1007/bf00577732

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  20 in total

1.  The prognostic significance of hypocholesterolemia in hospitalized patients.

Authors:  P Oster; H Muchowski; C C Heuck; G Schlierf
Journal:  Klin Wochenschr       Date:  1981-08-03

Review 2.  Low serum cholesterol, cancer and other noncardiovascular disorders.

Authors:  F H Epstein
Journal:  Atherosclerosis       Date:  1992-05       Impact factor: 5.162

3.  Prolonged infection with hepatitis B virus and association between low blood cholesterol concentration and liver cancer.

Authors:  Z Chen; A Keech; R Collins; B Slavin; J Chen; T C Campbell; R Peto
Journal:  BMJ       Date:  1993-04-03

4.  Elevated low density lipoprotein receptor activity in leukemic cells with monocytic differentiation.

Authors:  S Vitols; G Gahrton; A Ost; C Peterson
Journal:  Blood       Date:  1984-05       Impact factor: 22.113

5.  Risks of cancer of the colon and rectum in relation to serum cholesterol and beta-lipoprotein.

Authors:  S A Törnberg; L E Holm; J M Carstensen; G A Eklund
Journal:  N Engl J Med       Date:  1986-12-25       Impact factor: 91.245

6.  Relation between the frequency of colorectal adenoma and the serum cholesterol level.

Authors:  G A Mannes; A Maier; C Thieme; B Wiebecke; G Paumgartner
Journal:  N Engl J Med       Date:  1986-12-25       Impact factor: 91.245

7.  Cholesterol and mortality. 30 years of follow-up from the Framingham study.

Authors:  K M Anderson; W P Castelli; D Levy
Journal:  JAMA       Date:  1987-04-24       Impact factor: 56.272

8.  Assessing possible hazards of reducing serum cholesterol.

Authors:  M R Law; S G Thompson; N J Wald
Journal:  BMJ       Date:  1994-02-05

9.  The prognostic significance of total serum cholesterol in patients with Hodgkin's disease.

Authors:  C P Muller; B Trilling; B Steinke
Journal:  Cancer       Date:  1992-02-15       Impact factor: 6.860

10.  Plasma cholesterol concentration and mortality. The Whitehall Study.

Authors:  G D Smith; M J Shipley; M G Marmot; G Rose
Journal:  JAMA       Date:  1992-01-01       Impact factor: 56.272

View more
  9 in total

1.  [Hypolipoproteinemias].

Authors:  G Wolfram
Journal:  Internist (Berl)       Date:  2003-06       Impact factor: 0.743

2.  Apolipoprotein B Is an innate barrier against invasive Staphylococcus aureus infection.

Authors:  M Michal Peterson; Jessica L Mack; Pamela R Hall; Anny A Alsup; Susan M Alexander; Erin K Sully; Youhanna S Sawires; Ambrose L Cheung; Michael Otto; Hattie D Gresham
Journal:  Cell Host Microbe       Date:  2008-12-11       Impact factor: 21.023

3.  Plasma Lipids and Lipoproteins in Sickle Cell Disease Patients in the Northern West Bank, Palestine.

Authors:  Fekri Samarah; Mahmoud A Srour; Kamal Dumaidi
Journal:  Biomed Res Int       Date:  2021-08-04       Impact factor: 3.411

4.  Hypolipidemia: a word of caution.

Authors:  Rr Elmehdawi
Journal:  Libyan J Med       Date:  2008-06-01       Impact factor: 1.657

Review 5.  Intravenous lipids for preterm infants: a review.

Authors:  Ghassan Sa Salama; Mahmmoud Af Kaabneh; Mai N Almasaeed; Mohammad Ia Alquran
Journal:  Clin Med Insights Pediatr       Date:  2015-02-09

6.  The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.

Authors:  Takahiro Toyokawa; Naoshi Kubo; Tatsuro Tamura; Katsunobu Sakurai; Ryosuke Amano; Hiroaki Tanaka; Kazuya Muguruma; Masakazu Yashiro; Kosei Hirakawa; Masaichi Ohira
Journal:  BMC Cancer       Date:  2016-09-06       Impact factor: 4.430

7.  Higher values of triglycerides:HDL-cholesterol ratio hallmark disease severity in children and adolescents with sickle cell anemia.

Authors:  R S Teixeira; M B Arriaga; R Terse-Ramos; T A Ferreira; V R Machado; M R Rissatto-Lago; P S Silveira-Mattos; N Boa-Sorte; A M T Ladeia; B B Andrade
Journal:  Braz J Med Biol Res       Date:  2019-10-14       Impact factor: 2.590

8.  Effects of cholesterol levels on outcomes of out-of-hospital cardiac arrest: a cross-sectional study.

Authors:  Jong Hwan Kim; Dae Han Wi; Jun Hee Lee; Hyung Jun Song; Sang Do Shin; Young Sun Ro; Kwang-Ho Bae
Journal:  Clin Exp Emerg Med       Date:  2019-09-30

9.  Lower serum triglyceride level is a risk factor for in-hospital and late major adverse events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention- a cohort study.

Authors:  Yu-Tsung Cheng; Tsun-Jui Liu; Hui-Chin Lai; Wen-Lieng Lee; Hung-Yun Ho; Chieh-Shou Su; Chia-Ning Liu; Kuo-Yang Wang
Journal:  BMC Cardiovasc Disord       Date:  2014-10-10       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.